Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Birth Defects Res ; 115(7): 710-721, 2023 04 15.
Article in English | MEDLINE | ID: mdl-36929866

ABSTRACT

INTRODUCTION: It has been suggested that maternal exposure to constant light during the gestational period could be considered as a chronic stressor, impairing offspring development by interfering in neuroendocrine and behavior responses. OBJECTIVE: This study aimed to evaluate whether maternal exposure to continuous light during pregnancy affects the adult reproductive system in the female offspring. MATERIALS AND METHODS: Pregnant Wistar rats were allocated into light-dark (LD) group, exposed to light and dark photoperiod during gestation, and the light-light (LL) group, exposed to a photoperiod of constant light during gestation. After birth, pups were maintained under normal light-dark photoperiod until adulthood. At postnatal day 90, blood was collected from the female offspring, to analyze plasma luteinizing hormone (LH) and progesterone levels, and the uterus and ovaries were harvested for morphometric, histological, and oxidative stress evaluations. RESULTS AND DISCUSSION: Female exposure to continuous light during the intrauterine period resulted in the adult reduction of LH and increased progesterone plasma levels, and uterine injuries a higher number of endometrial glands and reduced levels of antioxidant enzymes, such as glutathione reductase and glutathione S-transferase. In these experimental conditions, gestational continuous light exposure disturbs sex hormone balance and reduces the antioxidant enzymatic activity in the uterus of female offspring in adult life.


Subject(s)
Antioxidants , Progesterone , Rats , Pregnancy , Animals , Female , Rats, Wistar , Luteinizing Hormone , Uterus
2.
J Appl Toxicol ; 43(2): 242-261, 2023 02.
Article in English | MEDLINE | ID: mdl-35962557

ABSTRACT

Parabens and phthalates are commonly found as contaminants in human fluids and are able to provoke reproductive toxicity, being considered endocrine disruptors. To evaluate the effects of phthalate and paraben, alone or in combination, on reproductive development of the offspring, female pregnant Wistar rats were allocated in six experimental groups: Three control groups (gavage [CG], subcutaneous [CS], and gavage + subcutaneous) received corn oil as vehicle, and the remaining groups were exposed to di(2-ethylhexyl)phthalate (DEHP) (500 mg/kg, gavage), butyl paraben (BP) (100 mg/kg, subcutaneously), or MIX (DEHP + BP), from Gestational Day 12 until Postnatal Day (PND) 21. The following parameters were assessed on the offspring: anogenital distance and weight at PND 1, nipple counting at PND 13, puberty onset, estrous cycle, weights of reproductive and detoxifying organs, histological evaluation of reproductive organs, and sperm evaluations (counts, morphology, and motility). Female pups from MIX group presented reduced body weight at PND 1, lower AGD, and decreased endometrium thickness. Male animals showed decreased body weight at PND 1 and lower number of Sertoli cells on DEHP and MIX groups, MIX group revealed increase of abnormal seminiferous tubules, DEHP animals presented delayed preputial separation and higher percentage of immotile sperms, and BP males presented diminished number of Leydig cells. In conclusion, the male offspring was more susceptible to DEHP toxicity; even when mixed to paraben, the main negative effects observed seem to be due to antiandrogenic phthalate action. On the other hand, DEHP seems to be necessary to improve the effects of BP on reducing estrogen-dependent and increasing androgen-dependent events.


Subject(s)
Diethylhexyl Phthalate , Prenatal Exposure Delayed Effects , Pregnancy , Humans , Rats , Animals , Male , Female , Maternal Exposure/adverse effects , Diethylhexyl Phthalate/toxicity , Parabens/toxicity , Rats, Sprague-Dawley , Rats, Wistar , Sexual Maturation , Semen , Body Weight , Prenatal Exposure Delayed Effects/chemically induced , Prenatal Exposure Delayed Effects/pathology , Testis
3.
Reprod Toxicol ; 107: 166-174, 2022 01.
Article in English | MEDLINE | ID: mdl-34968715

ABSTRACT

Cyantraniliprole is a synthetic insecticide used to control pests of up to 23 different types of crops. It is able to modulate ryanodine-like calcium channels, which are widely found in the organism of insects and mammals. The objective of this research was to verify the possible reproductive effects of adult female Wistar rats exposure to cyantraniliprole. Animals (67 days old) were exposed to the chemical at doses of 10 or 150 mg/kg/day, orally, for 28 consecutive days (control animals received only the vehicle). Vaginal secretions were collected during the exposure period to assess the regularity of the estrous cycle; the liver, kidneys, pituitary gland, adrenal gland, uterus, and ovaries were collected and weighed; reproductive organs were assessed for histopathological evaluation and for biochemical markers of oxidative stress and progesterone plasma level was measured. Both doses caused negative changes in the morphology and redox system of the uterus and ovaries. Animals exposed to 10 mg/kg also exhibited higher level of plasma progesterone, elevated levels of lipid peroxidation in reproductive organs, increased superoxide dismutase activity in the uterus and glutathione peroxidase activity on the ovary, while the 150 mg/kg group exhibited an increment in estrous cycle length and diminished uterine glandular epithelium. Based on these results, we conclude that cyantraniliprole may have acted as an endocrine disruptor, and its effects are mediated by oxidative stress.


Subject(s)
Endocrine Disruptors/toxicity , Insecticides/toxicity , Pyrazoles/toxicity , ortho-Aminobenzoates/toxicity , Animals , Cholinesterases/metabolism , Estrous Cycle/drug effects , Female , Glutathione Transferase/metabolism , Ovary/drug effects , Ovary/metabolism , Ovary/pathology , Oxidative Stress/drug effects , Oxidoreductases/metabolism , Progesterone/blood , Rats, Wistar , Reproduction/drug effects , Uterus/drug effects , Uterus/metabolism , Uterus/pathology
4.
J Appl Toxicol ; 40(7): 947-964, 2020 07.
Article in English | MEDLINE | ID: mdl-32072669

ABSTRACT

Many obese patients are exposed to hypolipidemic and serotonin-norepinephrine reuptake inhibitor (SNRI) drugs. Statins are one of the most marketed drugs in the world to treat dyslipidemia, while sibutramine, a SNRI drug, is prescribed in some countries to treat obesity and is detected as an additive in many adulterated weight loss supplements marketed worldwide. Previous studies reported adverse effects of isolated exposure to these drugs on male rat reproductive parameters. In the present work, we further investigated male reproductive toxicity of these drugs, administered in isolation or combination in adult rats for a longer period of treatment. Adult male rats (90 days) were treated (gavage) for 70 days with saline and dimethyl sulfoxide (control), sibutramine (10 mg/kg), rosuvastatin (5 mg/kg), or rosuvastatin combined with sibutramine. Sibutramine alone or with rosuvastatin, promoted a reduction in food intake and body weight gain, weight of the epididymis, ventral prostate and seminal vesicle; as well as decreased sperm reserves and transit time through the epididymis; androgen depletion; and increased index of cytoplasmic droplet. The rosuvastatin-treated group showed reduced frequency of ejaculation. Exposure to this drug alone or combined with sibutramine impaired epididymal morphology. Co-exposed rats had altered epididymal morphometry, and seminal vesicle and testis weights. The rats also showed decreased fertility after natural mating and a trend toward a delay in ejaculation, suggesting a small synergistic effect of these drugs. Given the greater reproductive efficiency of rodents, the results obtained in the present study raise concern regarding possible fertility impairment in men taking statins and SNRI drugs.


Subject(s)
Cyclobutanes/toxicity , Cyclobutanes/therapeutic use , Obesity/drug therapy , Reproductive Physiological Phenomena/drug effects , Rosuvastatin Calcium/toxicity , Rosuvastatin Calcium/therapeutic use , Testis/drug effects , Adult , Animals , Humans , Male , Models, Animal , Rats , Rats, Wistar
5.
J Toxicol Environ Health A ; 81(17): 873-892, 2018.
Article in English | MEDLINE | ID: mdl-30081759

ABSTRACT

Dyslipidemias are occurring earlier in different countries due to the increase of obesity, bad eating habits, and sedentary lifestyle. Rosuvastatin reduces serum cholesterol; however, several studies associated statin exposure with male reproduction impairment. Ascorbic acid (AA) is an antioxidant substance that plays a protective role in the male reproductive system. Male rats were randomly divided into 6 experimental groups (n = 10), which received saline solution 0.9%, 3 or 10 mg/kg/day of rosuvastatin, 150 mg/day of AA or 3 or 10 mg/kg/day of rosuvastatin associated with 150 mg/day of AA from post-natal day (PND) 23 until PND 53. On PND 100, males were mated with non-treated female rats to obtain the female pups. The day of vaginal opening and the first estrus were assessed in the offspring. Two sets of females were euthanized on the first estrus after PND 42 and PND 75 to evaluate the histology of reproductive organs and hormone levels. A third set was used for sexual behavior and fertility test around PND 75. Female offspring from males exposed or co-exposed to the higher dose of statin exhibited a lower number of corpora lutea during puberty. On sexual maturity, the experimental group from males that were exposed to 3 mg displayed lower uterine luminal epithelium area. Paternal exposure to rosuvastatin at pre-puberty diminished uterine luminal epithelium in female offspring suggesting epigenetic changes were initiated by statin. Ascorbic acid co-administered to pre-pubertal males was able to ameliorate the reproductive damage in rat female offspring in adulthood.


Subject(s)
Anticholesteremic Agents/administration & dosage , Antioxidants/administration & dosage , Ascorbic Acid/administration & dosage , Paternal Exposure , Reproduction/drug effects , Rosuvastatin Calcium/administration & dosage , Animal Feed/analysis , Animals , Diet , Dietary Supplements/analysis , Dose-Response Relationship, Drug , Female , Male , Random Allocation , Rats , Rats, Wistar
6.
Food Chem Toxicol ; 118: 416-429, 2018 Aug.
Article in English | MEDLINE | ID: mdl-29778496

ABSTRACT

Obesity during childhood and adolescence is closely related to dysfunctions on lipid profile in children. Rosuvastatin is a statin that decreases serum total cholesterol. Ascorbic acid is an important antioxidant compound for male reproduction. Pre-pubertal male rats were distributed into six experimental groups that received saline solution 0.9% (vehicle), 3 or 10 mg/kg/day of rosuvastatin, 150 mg/day of ascorbic acid, or 3 or 10 mg/kg/day of rosuvastatin co-administered with 150 mg/day of ascorbic acid by gavage from post-natal day (PND)23 until PND53. Rats were maintained until adulthood and mated with nulliparous females to obtain the male offspring, whose animals were evaluated at adulthood in relation to reproductive parameters. This study is a follow up of a previous paper addressing potential effects on F0 generation only (Leite et al., 2017). Male offspring from rosuvastatin-exposed groups showed increased sperm DNA fragmentation, androgen depletion and impairment on the testicular and epididymal structure. Ascorbic acid coadministered to the fathers ameliorated the reproductive damage in the offspring. In summary, paternal exposure to rosuvastatin may affect the reproduction in the male offspring; however, paternal supplementation with ascorbic acid was able to reduce the reproductive impairment in the male offspring caused by statin treatment to the fathers.


Subject(s)
Ascorbic Acid/pharmacology , Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects , Paternal Exposure , Prenatal Exposure Delayed Effects , Reproduction/drug effects , Rosuvastatin Calcium/adverse effects , Sexual Maturation , Animals , Ascorbic Acid/administration & dosage , Body Weight/drug effects , Dose-Response Relationship, Drug , Epididymis/drug effects , Female , Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage , In Situ Nick-End Labeling , Male , Organ Size/drug effects , Pregnancy , Rats, Wistar , Rosuvastatin Calcium/administration & dosage , Sexual Behavior, Animal , Sperm Count , Spermatogenesis/drug effects , Spermatozoa/drug effects , Testis/drug effects
7.
Environ Toxicol ; 32(3): 776-788, 2017 Mar.
Article in English | MEDLINE | ID: mdl-27120489

ABSTRACT

Parabens are used as preservatives in cosmetic, pharmaceutical, and food industries, and are frequently detected as contaminants in human fluids and tissues. The endocrine disrupting effects of parabens in female rodents include uterotrophic response, steroidogenesis impairment, and ovarian disturbances. The objective of this study was to determine the effects of maternal butyl paraben (BP) exposure on female sexual development. Pregnant Wistar rats were treated subcutaneously with either corn oil or BP at doses of 10, 100, or 200 mg/kg, from gestational day (GD) 12 until GD 20 for female foetal gonad evaluation, and from GD 12 until the end of lactation to evaluate sexual parameters on the female offspring. Immature female rats were also used in the uterotrophic assay to evaluate the possible estrogenic action of parabens. Our results revealed that, in this experimental protocol, BP did not show estrogenic activity at the doses used and did not impair sexual development and fertility capacity in the female rats, but impaired sexual behavior. We conclude that brain sexual development may be more sensitive to BP effects and we speculate that doses higher than 100 mg/kg (the male lowest observed adverse effect level (LOAEL) for rodent reproductive parameters) would be necessary to promote damages in the female reproduction, regarding the same protocol of exposure. © 2016 Wiley Periodicals, Inc. Environ Toxicol 32: 776-788, 2017.


Subject(s)
Endocrine Disruptors/toxicity , Fertility/drug effects , Parabens/toxicity , Reproduction/drug effects , Animals , Estrus/drug effects , Female , Hormones/blood , Humans , Lactation , Male , Maternal Exposure/adverse effects , Organ Size/drug effects , Ovary/drug effects , Ovary/pathology , Pregnancy , Rats , Rats, Wistar , Sexual Behavior, Animal/drug effects
8.
Reprod Toxicol ; 65: 29-38, 2016 10.
Article in English | MEDLINE | ID: mdl-27352640

ABSTRACT

Exposure to Tetrachlorodibenzo-p-dioxin (TCDD) in male rats promotes, decreased sperm concentration, alterations in motility and in sperm transit time. We evaluated the effect transgenerational of in utero exposure to low doses TCDD in the sperm quality. Pregnant rats (F0) were exposed to 0.1; 0.5 and 1.0µg of TCDD, on gestational day 15, coincides with the end of most organogenesis in the fetus. Adult male offspring (F1, F2 and F3 generation) were investigated for fertility after artificial insemination in utero. After collection of the uterus and ovaries, the numbers of corpora lutea and implants were determined. TCDD provoked alterations in sperm morphology and diminution in serum testosterone levels and sperm transit time in the cauda epididymis. The fertility significantly decreased in all the generations, at least at one dose. In conclusion, TCDD exposure decreases rat sperm quality and fertility in adult male offspring and this effects persist into the next generation.


Subject(s)
Environmental Pollutants/toxicity , Fertility/drug effects , Polychlorinated Dibenzodioxins/toxicity , Prenatal Exposure Delayed Effects , Spermatozoa/drug effects , Animals , Female , Male , Pregnancy , Rats, Wistar , Sperm Count , Sperm Motility/drug effects , Spermatozoa/physiology , Testosterone/blood
9.
J Toxicol Environ Health A ; 78(8): 481-91, 2015.
Article in English | MEDLINE | ID: mdl-25849765

ABSTRACT

Prochloraz (PCZ) is a fungicide and androgen-receptor antagonist used worldwide in horticulture and agriculture. Pre- and perinatal exposure to this pesticide during sexual differentiation is deleterious for male offspring. Since data on the effects of PCZ on epididymal functions are scarce, and because sperm maturation occurs in this organ, the present investigation aimed to determine whether low PCZ doses administered to rats during the phase of sperm transit through the epididymis might affect the morphophysiology of this organ and sperm quality. Adult male Wistar rats were assigned to 4 different groups: 0 (control, vehicle) or 10, 15, or 30 mg/kg bw/d PCZ diluted in corn oil administered orally for 4 consecutive days. Morphofunctional parameters of the male reproductive tract, hormone concentrations, sperm evaluations, and fertility and histopathologic analysis of testis and epididymis were assessed. There were no statistically significant differences between treated and control groups in relation to all evaluated parameters. Data demonstrated show that PCZ exposure for a brief 4-d exposure and low doses did not produce reproductive toxicity or compromise sperm quality in adult rats.


Subject(s)
Androgen Antagonists/toxicity , Epididymis/drug effects , Fertility/drug effects , Fungicides, Industrial/toxicity , Imidazoles/toxicity , Spermatogenesis/drug effects , Testis/drug effects , Administration, Oral , Androgen Antagonists/adverse effects , Animals , Body Weight/drug effects , Dose-Response Relationship, Drug , Epididymis/cytology , Epididymis/growth & development , Female , Fungicides, Industrial/administration & dosage , Humans , Imidazoles/administration & dosage , Insemination, Artificial , Male , Organ Size/drug effects , Random Allocation , Rats, Wistar , Semen Analysis , Testis/cytology , Testis/growth & development , Toxicity Tests, Subacute
10.
Toxicology ; 262(3): 215-23, 2009 Aug 21.
Article in English | MEDLINE | ID: mdl-19549552

ABSTRACT

In the present study we evaluated the toxic effects on the male adult rat prostate of DBP exposure during fetal and lactational periods, because although many studies have addressed the influence of phthalates on the male reproductive system, only a few have discussed their possible effects on prostate development. Pregnant females were distributed into two experimental groups: Control (C) and Treated (T). The females of the T group received DBP (100mg/kg, by gavage) from gestation day 12 to postnatal day 21, while C rats received the vehicle (corn oil). In adulthood (90 days old), the animals were euthanized. The serum and testicular testosterone levels were measured. Ventral prostate was removed and weighed. Distal segment fragments of the ventral prostate were fixed and processed for histochemistry and immunohistochemistry to detect androgen receptor (AR) and Ki67 antigens. Protein extraction from ventral prostate fragments was performed for AR immunoblotting and Gelatin zymography for MMP-2 and MMP-9 (MMP, metalloproteinase). Stereological and histopathological analyses were also performed. Serum and testicular testosterone levels and prostate weight were comparable between groups. In the T group the relative proportions (%) of epithelial (C=32.86; T=42.04*) and stromal (C=21.61; T=27.88*) compartments were increased, while the luminal compartment was decreased (C=45.54; T=30.08*), *p<0.05. InT, disseminated inflammatory infiltrate in the stroma, associated or not with epithelial dysplasia and PIN (Prostatic Intraepithelial Neoplasia), was observed. Increases in AR expression, proliferation index and metalloproteinase 9 (MMP-9) activity were noted in T animals. In some T animals, collagen fibrils accumulated adjacent to the epithelium. As far as we are aware, this is the first report in the literature showing that phthalates could play a role in proliferative and inflammatory disorders of the rat prostate.


Subject(s)
Dibutyl Phthalate/toxicity , Prostate/drug effects , Receptors, Androgen/drug effects , Testosterone/metabolism , Animals , Cell Proliferation/drug effects , Epithelial Cells/metabolism , Female , Gene Expression Regulation/drug effects , Immunohistochemistry , Ki-67 Antigen/drug effects , Ki-67 Antigen/metabolism , Male , Matrix Metalloproteinase 2/drug effects , Matrix Metalloproteinase 2/metabolism , Matrix Metalloproteinase 9/drug effects , Matrix Metalloproteinase 9/metabolism , Pregnancy , Prenatal Exposure Delayed Effects , Prostate/metabolism , Prostatic Intraepithelial Neoplasia/chemically induced , Rats , Rats, Wistar , Receptors, Androgen/genetics , Receptors, Androgen/metabolism , Stromal Cells/drug effects , Stromal Cells/metabolism , Testis/metabolism , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...